Valeant Pharmaceuticals's ticker is VRX and the CUSIP is 91911X104. A total of 2 filers reported holding Valeant Pharmaceuticals in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $1,000 | -94.4% | 25 | -84.1% | 0.00% | -90.9% |
| Q4 2013 | $18,000 | +12.5% | 157 | 0.0% | 0.01% | -8.3% |
| Q3 2013 | $16,000 | +433.3% | 157 | +406.5% | 0.01% | +500.0% |
| Q2 2013 | $3,000 | -80.0% | 31 | -84.1% | 0.00% | -87.5% |
| Q1 2013 | $15,000 | +25.0% | 195 | -1.5% | 0.02% | +6.7% |
| Q4 2012 | $12,000 | – | 198 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Long Wharf Investors, Inc. | 6,488 | $762,000 | 0.69% |
| TCI Wealth Advisors, Inc. | 157 | $18,000 | 0.01% |